Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,460 public trials 1,142 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Active, Not Recruiting

Omission of SLNB in Triple-negative and HER2-positive Breast Cancer Patients With rCR and pCR in the Breast After NAST

NCT04101851

Conditions
Breast Cancer, Breast Cancer Female, Breast Diseases, +5 more
Locations
  • Med. Universität Graz, Frauenklinik Graz, Austria
  • Praxis Dres. Heinrich & Bangerter Augsburg, Germany
  • Universitäts-Klinikum, Frauenklinik Augsburg, Germany
  • Klinikum Mittelbaden Brustzentrum Baden-Baden, Germany
View all 40 locations
View Trial Details
Active, Not Recruiting

CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer

NCT02918084

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Ospedale Santo SpiritoH Casale Monferrato, AL, Italy
  • Ospedale di Rete 'Engles Profili' - A.S.U.R. Area Vasta 2 Fabriano, AN, Italy
  • A.O. San Giuseppe Moscati Avellino, AV, Italy
  • Istituto Tumori 'Giovanni Paolo II' - IRCCS Ospedale Oncologico Bari, BA, Italy
View all 74 locations
View Trial Details
Active, Not Recruiting

PF-07104091 as a Single Agent and in Combination Therapy

NCT04553133

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +27 more
Locations
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Clive, Iowa, United States
  • Des Moines Oncology Research Association Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
  • Medical Oncology & Hematology Associates DBA Mission Cancer and Blood Des Moines, Iowa, United States
View all 22 locations
View Trial Details
Active, Not Recruiting

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C)

NCT06125522

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Clinical and Translational Research Unit (CTRU) Palo Alto, California, United States
View all 21 locations
View Trial Details
Active, Not Recruiting

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

NCT05104866

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site San Francisco, California, United States
View all 167 locations
View Trial Details

Related conditions